Nepal vs Singapore: Immunization, Hib3
Nepal
97.0%
in 2024
Singapore
97.0%
in 2024
Nepal rank
29th
Singapore rank
29th
Immunization, Hib3 over time
- Nepal
- Singapore
How they compare
Nepal currently reports 97.0% against 97.0% in Singapore, a difference of 0.0%.
The two have swapped places 1 time across 12 shared years of data; in 2013 it was Nepal ahead.
Nepal ranks 29th and Singapore ranks 29th of 191 countries.
Singapore has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nepal | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 90.9% | 93.1% | 2.3% | Singapore |
| 2020s | 91.2% | 97.6% | 6.4% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Nepal or Singapore?
- Nepal, at 97.0% against 97.0% in Singapore as of 2024.
- What is the difference in immunization, hib3 between Nepal and Singapore?
- 0.0%, with Nepal ahead.
- How many years of comparable data are there for Nepal and Singapore?
- 12 years are reported by both, from 2013 to 2024.
- How do Nepal and Singapore rank globally for immunization, hib3?
- Nepal ranks 29th and Singapore ranks 29th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.